Sinha Vikas (CIK 1337845) reported 23 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-04-20). Recent activity: Sell SRRK (10,410 shares), Buy SRRK (47,021 shares), Sell SRRK (16,755 shares), Sell VRNA (94,112 shares), Buy VRNA (72,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Scholar Rock Holding Corp (SRRK) | Chief Financial Officer | Sell | 10,410 | $516,071 |
| 2026-02-11 | Scholar Rock Holding Corp (SRRK) | Chief Financial Officer | Buy | 47,021 | $0 |
| 2026-01-15 | Scholar Rock Holding Corp (SRRK) | Chief Financial Officer | Sell | 16,755 | $715,438 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Sell | 94,112 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Buy | 72,000 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Sell | 72,000 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Director | Buy | 24,000 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Director | Sell | 4,328 | $56,870 |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Buy | 160,000 | $80,000 |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Sell | 160,000 | $1.5M |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Buy | 120,384 | $204,653 |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Sell | 120,384 | $1.1M |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Buy | 39,616 | $19,808 |
| 2025-05-22 | Verona Pharma plc (VRNA) | Director | Sell | 39,616 | $353,375 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Director | Buy | 15,048 | $25,582 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Director | Sell | 15,048 | $134,228 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Director | Buy | 4,952 | $2,476 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Director | Sell | 4,952 | $44,172 |
| 2025-04-29 | Scholar Rock Holding Corp (SRRK) | Chief Financial Officer | Buy | 100,000 | $0 |
| 2025-04-29 | Scholar Rock Holding Corp (SRRK) | Chief Financial Officer | Buy | 500,000 | $0 |
| 2025-02-24 | Allovir, Inc. (ALVR) | See Remarks | Sell | 303 | $3,054 |
| 2025-01-27 | Allovir, Inc. (ALVR) | See Remarks | Sell | 116 | $1,096 |
| 2025-01-27 | Allovir, Inc. (ALVR) | See Remarks | Sell | 13 | $129 |
Source: SEC Form 4 filings · as of 2026-04-20